Capital Flow Monitor · Sponsors · CIK 1533040
Phio Pharmaceuticals Corp.
411 SWEDELAND ROAD, KING OF PRUSSIA, PA, 19406 · 760-943-1088
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$25.9M
Sold
$1.4M
% sold
5.5%
Investors
5
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | D ·current | 506(b) | $25.9M | $1.4M | 5.5% | 5 | EDGAR ↗ |
| 2025-08-04 | D | 506(b) | $5.1M | $232K | 4.6% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Robert J. Bitterman — Director / Executive Officer, King of Prussia, PA
- Patricia A. Bradford — Director, King of Prussia, PA
- Jonathan Freeman — Director, King of Prussia, PA
- Curtis Lockshin, Ph.D. — Director, King of Prussia, PA
- David H. Deming — Director, King of Prussia, PA
- Lisa Carson — Executive Officer, King of Prussia, PA
Placement agents
- H.c. Wainwright & Co., Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.